Abstract
Novel small molecules were designed to specifically target the ligand-binding pocket of a PDZ domain. Iterative molecular docking and modeling allowed the design of an indole scaffold 10a as a reversible inhibitor of ligand binding. The 10a scaffold inhibited the interaction between MAGI-3 and PTEN and showed cellular activities that are consistent with the inhibition of NHERF-1 function.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 549-552 |
| Number of pages | 4 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 17 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 15 2007 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Drug design
- Interaction
- NHERF
- PDZ domain
- Protein-protein
Fingerprint
Dive into the research topics of 'Rational design of a nonpeptide general chemical scaffold for reversible inhibition of PDZ domain interactions'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS